Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001209191-23-048968

Chief Business Officer gave up 9,383 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gallagher Patrick Stephen Chief Business Officer 2023-02-15 Shares withheld for taxes −9,383 $1.50 $14,075 34,130 D
Loading xslF345X05/doc4.xml…